Novel targets for the future development of antibacterial agents (Q34631428)

3 August 2017

1 reference

title

Novel targets for the future development of antibacterial agents. (English)

1 reference

3 August 2017

McDevitt D

1

1 reference

3 August 2017

Payne DJ

series ordinal

2

1 reference

3 August 2017

Holmes DJ

series ordinal

3

1 reference

3 August 2017

Rosenberg M

series ordinal

4

1 reference

3 August 2017

publication date

1 January 2002

1 reference

Journal of Applied Microbiology

3 August 2017

published in

1 reference

3 August 2017

volume

92 Suppl

1 reference

3 August 2017

page(s)

28S-34S

1 reference

A genome-based approach for the identification of essential bacterial genes.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Gram-positive resistance: challenge for the development of new antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Hospital-acquired infections: diseases with increasingly limited therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

A genomic analysis of two-component signal transduction in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2672.92.5S1.16.X

10.1046/J.1365-2672.92.5S1.16.X

21 January 2018

Identifiers

DOI

1 reference

release_gwz4pjpw3vdydofnnetek6na3e

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwz4pjpw3vdydofnnetek6na3e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference